Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis

Journal of Interferon and Cytokine Research

Volumn 26, Issue 6, 2006, Pages 390-399

  Brown, Charles R ^a,b   Blaho, Victoria A ^a   Fritsche, Kevin L ^a,b   Loiacono, Christie M ^b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTHRITIS; ARTICLE; BACTERIAL COUNT; BORRELIA BURGDORFERI; CARDITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE RESISTANCE; DISEASE SEVERITY; EXPERIMENTAL INFECTION; INFECTION SENSITIVITY; INFLAMMATION; KNOCKOUT MOUSE; LYME DISEASE; MACROPHAGE ACTIVATION; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS; BORRELIA BURGDORFERI GROUP; CROSSES, GENETIC; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, INBRED DBA; MICE, INBRED STRAINS; MYOCARDITIS; STAT1 TRANSCRIPTION FACTOR;

BACTERIA (MICROORGANISMS); MURINAE; SPIROCHAETALES;

EID: 33744961453     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.390     Document Type: Article

References (54)

1. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 1990;162:133-138.
2. Weis JJ. Host-pathogen interactions and the pathogenesis of murine Lyme disease. Curr. Opin. Rheumatol. 2002;14:399-403.
3. Brown CR, Reiner SL. Clearance of Borrelia burgdorferi may not be required for resistance to experimental Lyme arthritis. Infect. Immun. 1998;66:2065-2071.
4. Ma Y, Seiler KP, Eichwald EJ, Weis JH, Teuscher C, Weis JJ. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 1998;66:161-168.
5. Armstrong AL, Barthold SW, Persing DH, Beck DS. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 1992;47:249-258.
6. Schaible UE, Kramer MD, Museteanu C, Zimmer G, Mossmann H, Simon MM. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J. Exp. Med. 1989;170:1427-1432.
7. Barthold SW, Sidman CL, Smith AL. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 1992;47:605-613.
8. Barthold SW, deSouza M, Feng S. Serum-mediated resolution of Lyme arthritis in mice. Lab. Invest. 1996;74:57-67.
9. McKisic MD, Barthold SW. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect. Immun. 2000;68:5190-5197.
10. + T helper 1 cells facilitate regression of murine Lyme carditis. Infect. Immun. 2001;69:5264-5269.
11. + T cell interactions. J. Infect. Dis. 1995;171:362-370.
12. Montgomery RR, Lusitani D, Chevance Ad AB, Malawista SE. Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J. Infect. Dis. 2002;185:1773-1779.
13. Habicht GS, Beck G, Benach JL, Coleman JL, Leichtling KD. Lyme disease spirochetes induce human and murine interleukin 1 production. J. Immunol. 1985;134:3147-3154.
14. Radolf JD, Arndt LL, Akins DR, Curetty LL, Levi ME, Shen Y, Davis LS, Norgard MV. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 1995;154:2866-2877.
15. Murthy PK, Dennis VA, Lasater BL, Philipp MT. Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect. Immun. 2000;68:6663-6669.
16. Ma Y, Weis JJ. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 1993;61:3843-3853.
17. Ethuin F, Gerard B, Benna JE, Boutten A, Gougereot-Pocidalo MA, Jacob L, Chollet-Martin S. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab. Invest. 2004;84:1363-1371.
18. Ellis TN, Beaman BL. Interferon-γ activation of polymorphonuclear neutrophil function. Immunology 2004;112:2-12.
19. Brown CR, Blaho VA, Loiacono CM. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 2003;171:893-901.
20. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon α/β-mediated inhibition and promotion of interferon gamma: Stat1 resolves a paradox. Nat. Immunol. 2000;1:70-76.
21. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 2001;98:6680-6685.
22. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. USA 2001;98:6674-6679.
23. Qing Y, Stark GR. Alternative activation of Stat1 and Stat3 in response to interferon-γ. J. Biol. Chem. 2004;279:41679-41685.
24. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996;84:443-450.
25. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguel M, Schreiber RD. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the Jak-Stat signaling pathway. Cell 1996;84:431-442.
26. Ohmori Y, Hamilton TA. Requirement for Stat1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 2001;69:598-604.
27. Gold JA, Hoshino Y, Hoshino S, Jones MB, Nolan A, Weiden MD. Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect. Immun. 2004;72:1291-1297.
28. Sugawara I, Yamada H, Mizuno S. Stat1 knockout mice are highly susceptible to pulmonary mycobacterial infection. Tohoku J. Exp. Med. 2004;202:41-50.
29. Rosas LE, Keiser T, Pyles R, Durbin J, Satoskar AR. Development of protective immunity against cutaneous leishmaniasis is dependent on Stat1-mediated IFN signaling pathway. Eur. J. Immunol. 2003;33:1799-1805.
30. Lieberman LA, Banica M, Reiner SL, Hunter CA. Stat1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J. Immunol. 2004;172:457-463.
31. Fallarino F, Gajewski TF. Cutting edge: Differentiation of antitumor CTL in vivo requires host expression of Stat1. J. Immunol. 1999;163:4109-4113.
32. 2 integrins control the severity of murine Lyme carditis. Infect. Immun. 2005;73:3242-3250.
33. Morrison TB, Ma Y, Weis JH, Weis JJ. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J. Clin. Microbiol. 1999;37:987-992.
34. Pahl A, Kuhlbrandt U, Brune K, Rollinghoff M, Gessner A. Quantitative detection of Borrelia burgdorferi by real-time PCR. J. Clin. Microbiol. 1999;37:1958-1963.
35. Schoenfeld R, Araneo B, Ma Y, Yang LM, Weis JJ. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect. Immun. 1992;60:455-464.
36. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988;141:2407-2412.
37. Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 2004;72:3195-3203.
38. Montgomery RR, Nathanson MH, Malawista SE. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery. J. Immunol. 1993;150:909-915.
39. Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, Moran TM, Vukmanovic S, Garcia-Sastre A, Levy DE. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 2000;164:4220-4228.
40. Ma Y, Seiler KP, Tai KF, Yang L, Woods M, Weis JJ. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect. Immun. 1994;62:3663-3671.
41. Modolell M, Schaible UE, Rittig M, Simon MM. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol. Lett. 1994;40:139-146.
42. Brown CR, Reiner SL. Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 1999;67:3329-3333.
43. Potter MR, Noben-Trauth N, Weis JH, Teuscher C, Weis JJ. Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes. Infect. Immun. 2000;68:5603-5609.
44. Glickstein L, Edelstein M, Dong JZ. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model. Infect. Immun. 2001;69:3737-3743.
45. Keane-Myers A, Nickell SP. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 1995;155:2020-2028.
46. Matyniak JE, Reiner SL. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 1995;181:1251-1254.
47. Ganapamo F, Dennis VA, Philipp MT. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi. Infect. Immun. 2000;68:7162-7165.
48. Kang I, Barthold SW, Persing DH, Bockenstedt LK. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect. Immun. 1997;65:3107-3111.
49. Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, Ernerudh J. Borrelia-specific interferon-γ and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J. Infect. Dis. 2004;189:1881-1891.
50. Gross DM, Steere AC, Huber BT. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 1998;160:1022-1028.
51. Zimmer G, Schaible UE, Kramer MD, Mall G, Museteanu C, Simon MM. Lyme carditis in immunodeficient mice during experimental infection of Borrelia burgdorferi. Virchows Arch. A Pathol. Anat. Histopathol. 1990;417:129-135.
52. -/- mice. Infect. Immun. 2005;73:7637-7643.
53. Kelleher DM, Telford SR, Criscione L, Lin SR, Spielman A, Gravallese EM. Cytokines in murine Lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain. J. Infect. Dis. 1998;177:242-246.
54. Montgomery RR, Wang XM, Malawista SE. Murine Lyme disease: no evidence for active immune down-regulation in resolving or subclinical infection. J. Infect. Dis. 2001;183:1631-1637.